מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
teicoplanin, Quantity: 400 mg
Southern Cross Pharma Pty Ltd
Teicoplanin
Injection, powder for
Excipient Ingredients: sodium hydroxide; sodium chloride
Intravenous, Intramuscular
1 vial, 1 diluent ampoule
(S4) Prescription Only Medicine, Not scheduled. Not considered by committee
Teicoplanin is indicated for the treatment of the following serious infections due to Staphylococci or Streptococci, which cannot be treated satisfactorily with less toxic agents, including beta-lactam antibiotics: bone (osteomyelitis); joints (septic arthritis); blood (noncardiac bacteraemia, septicaemia).
Visual Identification: white to pale yellow, sterile lyophilised powder; Container Type: Multiple containers; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-06-07